Keyphrases
Epithelial-mesenchymal Transition
100%
Hepatocellular Carcinoma
100%
Bone Morphogenetic Protein 4 (BMP4)
83%
Oxaliplatin Resistance
66%
Metastasis
35%
CRISPR Interference (CRISPRi)
33%
Tumorigenesis
27%
Phosphorylation
23%
Oxaliplatin
20%
Paclitaxel Chemosensitivity
20%
Cyclin-dependent Kinase 1 (CDK1)
20%
Mitosis
20%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
20%
Mitotic Progression
18%
Pancreatic Cancer
18%
Cell Invasion
18%
B-cell Lymphoma 2 (Bcl-2)
17%
HCT116
17%
Knockdown
16%
BCL2L1
16%
CDKN1B
16%
MARK2
16%
Ovarian Cancer
16%
MEK1
16%
Colorectal Cancer
16%
Primary Tumor Resection
16%
Kirrel
16%
Independent Pathway
16%
Stage IV Colorectal Cancer
16%
Topoisomerase II Poison
16%
Neferine
16%
Etoposide
16%
Instrumental Analysis
16%
Cell Cycle Progression
16%
Radiotherapy
16%
Long Non-coding RNA (LncRNA)
16%
Colon Cancer Cells
16%
Left-handed
16%
Tyrosyl-DNA Phosphodiesterase 1 (TDP1)
16%
LINC00963
16%
MiR-204-3p
16%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
16%
FOXC2
16%
Antisense
16%
Radiation Therapy
16%
Gastric Cancer
16%
MAPK-ERK Signaling
16%
Synthetic Lethality
16%
Protein Kinase
16%
Synthetic Lethal
16%
Biochemistry, Genetics and Molecular Biology
Bone Morphogenetic Protein 4
83%
CRISPR
79%
Mesenchymal-Epithelial Transition
66%
DNA Damage
35%
Cancer Cell
34%
Carcinogenesis
33%
ID2
33%
DNA Gyrase
33%
DNA Damage Response
33%
Autophagy
30%
Tumor Progression
25%
Anticancer
24%
Long Noncoding RNA
23%
RNA Sequence
22%
Flow Cytometry
19%
Immunity
18%
extracellular signal regulated kinase
16%
Antisense
16%
Cyclin-Dependent Kinase 1
16%
Serine
16%
Phosphodiesterase
16%
Synapsin I
16%
CDKN1B
16%
MARK2
16%
DNA Repair
16%
Independent Pathway
16%
Pan-cancer
16%
Isoform
16%
Cell Cycle Progression
16%
ID1
16%
BRCA1
16%
Cell Surface Protein
16%
Tumor Suppressor Gene
16%
ELK1
16%
Immune Checkpoints
16%
Fibronectin
16%
Colon
16%
Bcl-2
16%
Syngenic
13%
Immune Evasion
11%
Proteasome
10%
Drug Resistance
10%
Cell Survival
10%
Cell Invasion
10%
Western Blot
10%
Drug Megadose
8%
Programmed Cell Death
8%
Tumor Suppressor Protein
8%
Transcriptomics
7%
Luciferase
6%
Pharmacology, Toxicology and Pharmaceutical Science
Oxaliplatin
66%
Liver Cell Carcinoma
66%
Paclitaxel
33%
Colon Carcinoma
33%
Bone Morphogenetic Protein 4
33%
Malignant Neoplasm
30%
Neoplasm
21%
Long Untranslated RNA
19%
Carcinogenesis
19%
Breast Cancer
18%
LIM Protein
16%
Pancreas Cancer
16%
Synapsin I
16%
Lethality
16%
B Cell Lymphoma
16%
Protein SH3
16%
Protein Kinase
16%
Neferine
16%
Osteosarcoma
16%
Cyclin Dependent Kinase Inhibitor 1B
16%
Beclin 1
16%
Ovary Cancer
16%
Transcription Factor ZEB1
16%
Fibronectin
16%
Colorectal Carcinoma
16%
Drug Resistance
14%
Tumor Growth
9%
Cytotoxicity
8%
Western Blot
8%
Antiapoptotic
8%
Apoptosis Inhibitor
8%
Chemotherapy
8%
Small Interfering RNA
5%
Histone Deacetylase 4
5%
